摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4β-azido-4-deoxy-4′-demethylepipodophyllotoxin | 117604-05-4

中文名称
——
中文别名
——
英文名称
4β-azido-4-deoxy-4′-demethylepipodophyllotoxin
英文别名
4β-azido-4'-demethylepipodophyllotoxin;4β-azido-4-deoxy-4'-demethypodophyllotoxin;4β-azido-4-deoxy-4'-demethylpodophyllotoxin;(5R,5aR,8aS,9S)-9-azido-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4': 6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one;(5S,5aS,8aR,9R)-5-azido-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one
4β-azido-4-deoxy-4′-demethylepipodophyllotoxin化学式
CAS
117604-05-4
化学式
C21H19N3O7
mdl
——
分子量
425.398
InChiKey
JGNBIEBOJZWEKG-JHQYFNNDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    31
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    97.8
  • 氢给体数:
    1
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8

反应信息

  • 作为反应物:
    描述:
    4β-azido-4-deoxy-4′-demethylepipodophyllotoxin 在 palladium on activated charcoal 氢气 作用下, 以70%的产率得到(5R,5aR,8aS,9S)-9-amino-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one
    参考文献:
    名称:
    新型鬼臼毒素衍生物的合成及其抗HIV-1活性。
    摘要:
    为了探索鬼臼毒素化合物类别的生物活性范围,设计,合成了鬼臼毒素的一系列新衍生物,这些衍生物是含有司他夫定和不同结构鬼臼毒素类似物的结合物,并评估了它们的抗HIV-1活性。体外。在这些化合物中,19d和19c显示最高的抗HIV-1活性,EC(50)值为0.17和0.29 microM,TI值分别为466.9和354.5。
    DOI:
    10.1016/j.bmcl.2006.11.070
  • 作为产物:
    参考文献:
    名称:
    新型鬼臼毒素衍生物的合成及其抗HIV-1活性。
    摘要:
    为了探索鬼臼毒素化合物类别的生物活性范围,设计,合成了鬼臼毒素的一系列新衍生物,这些衍生物是含有司他夫定和不同结构鬼臼毒素类似物的结合物,并评估了它们的抗HIV-1活性。体外。在这些化合物中,19d和19c显示最高的抗HIV-1活性,EC(50)值为0.17和0.29 microM,TI值分别为466.9和354.5。
    DOI:
    10.1016/j.bmcl.2006.11.070
点击查看最新优质反应信息

文献信息

  • Synthesis and Anticancer Activity of Glucosylated Podophyllotoxin Derivatives Linked via 4β-Triazole Rings
    作者:Cheng-Ting Zi、Feng-Qing Xu、Gen-Tao Li、Yan Li、Zhong-Tao Ding、Jun Zhou、Zi-Hua Jiang、Jiang-Miao Hu
    DOI:10.3390/molecules181113992
    日期:——
    A series of 4β-triazole-linked glucose podophyllotoxin conjugates have been designed and synthesized by employing a click chemistry approach. All the compounds were evaluated for their anticancer activity against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, SW480) using MTT assays. Most of these triazole derivatives have good anticancer activity. Among them, compound 35 showed the highest potency against all five cancer cell lines tested, with IC50 values ranging from 0.59 to 2.90 μM, which is significantly more active than the drug etoposide currently in clinical use. Structure-activity relationship analysis reveals that the acyl substitution on the glucose residue, the length of oligoethylene glycol linker, and the 4'-demethylation of podophyllotoxin scaffold can significantly affect the potency of the anticancer activity. Most notably, derivatives with a perbutyrylated glucose residue show much higher activity than their counterparts with either a free glucose or a peracetylated glucose residue.
    通过点击化学方法,设计并合成了系列4β-三氮唑连接的葡萄糖鬼臼毒素缀合物。所有化合物均通过MTT法对其在五种人癌细胞系(HL-60,SMMC-7721,A-549,MCF-7,SW480)中的抗癌活性进行了评估。这些三氮唑衍生物大多具有良好的抗癌活性。其中,化合物35对所有五种癌细胞系的活性最高,IC50值在0.59至2.90 μM之间,其活性显著高于临床使用的药物依托泊苷。结构-活性关系分析显示,葡萄糖残基上的酰基取代、聚乙烯 glycol 链的长度以及鬼臼毒素骨架的4'-脱甲基化对抗癌活性的强度有显著影响。特别值得注意的是,具有完全丁酰化的葡萄糖残基的衍生物比具有游离葡萄糖或完全乙酰化葡萄糖残基的对照组活性高得多。
  • Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II
    作者:Xiao Ming Zhou、Zhe Qing Wang、Jang Yang Chang、Hong Xing Chen、Yung Chi Cheng、Kuo Hsiung Lee
    DOI:10.1021/jm00116a001
    日期:1991.12
    The most active compounds are 14, 16, and 17, which are more than 2-fold more potent than 1. The results indicated that a basic unsubstituted 4 beta-benzylamino moiety is structurally required for the enhanced activity. Replacement of the benzyl nitrogen with oxygen gave compounds (23 and 24) which are inactive. The ability of these compounds to inhibit human DNA topoisomerase II and to cause protein-linked
    已经合成了许多具有各种4β-N-或4β-O-苄基的新的4'-O-去甲基表鬼臼毒素衍生物,并评估了其对人DNA拓扑异构酶II的抑制活性以及在引起细胞凋亡方面的活性。蛋白质相关的DNA断裂。4种β-N-苄基衍生物9-22通常具有活性,或具有比依托泊苷(1)更高的活性。活性最高的化合物是14、16和17,它们的效力比1强2倍以上。结果表明,增强的活性在结构上需要碱性的未取代的4β-苄基氨基部分。用氧代替苄基氮得到惰性的化合物(23和24)。
  • Synthesis and antitumor activity of camptothecin- 4β-triazolopodophyllotoxin conjugates
    作者:Cheng-Ting Zi、Liu Yang、Fa-Wu Dong、Qing-Hua Kong、Zhong-Tao Ding、Jun Zhou、Zi-Hua Jiang、Jiang-Miao Hu
    DOI:10.1080/14786419.2018.1538223
    日期:2020.8.17
    Two new compounds (9 and 10) having a camptothecin (CPT) analog conjugated to the 4β-azido-4-deoxypodophyllotixin analog by untilizing the copper-catalyzed azide-alkyne cycloadditon (CuAAC) reaction, and were evaluated for their cytotoxicity against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7 and SW480) using the MTT (3-(4,5-dimethyl-thiahiazo-2-yl)-2,5-diphenyltetrazolium
    将喜树碱(CPT)类似物偶联至4β-叠氮基4-脱氧鬼臼毒素类似物直到铜催化的叠氮化物-炔烃环己二酮(CuAAC)反应偶联后的两个新化合物(9和10),并评估其对面板的细胞毒性MTT(3-(4,5-二甲基-噻唑基-2-基)-2,5-二苯基四唑鎓)检测五个人类癌细胞系(HL-60,SMMC-7721,A-549,MCF-7和SW480)溴化物)分析。两种新型缀合物显示出弱的细胞毒性,化合物10显示出对测试的HL-60细胞系的强效作用,IC 50值为17.69±0.19μM。该化合物表明其作为抗癌剂具有进一步开发的潜力。
  • Design, Synthesis, and Cytotoxicity of Perbutyrylated Glycosides of 4β-Triazolopodophyllotoxin Derivatives
    作者:Cheng-Ting Zi、Zhen-Hua Liu、Gen-Tao Li、Yan Li、Jun Zhou、Zhong-Tao Ding、Jiang-Miao Hu、Zi-Hua Jiang
    DOI:10.3390/molecules20023255
    日期:——
    A series of novel perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives were synthesized by utilizing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. Evaluation of cytotoxicity against a panel of five human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, SW480) using the MTT assay shows that some of these glycosylated derivatives have good anticancer activity. Among the synthesized compounds, compound 21a shows the highest activity, with IC50 values ranging from 0.49 to 6.70 μM, which is more potent than the control drugs etoposide and cisplatin. Compound 21a is characterized by a perbutyrylated α-D(+)-galactosyl residue, the absence of an additional linking spacer between the sugar residue and the triazole ring, as well as a 4'-OH group on the E ring of the podophyllotoxin scaffold.
    一系列新颖的4β-三唑基鬼臼毒素衍生物的全丁酰化糖苷通过铜催化的叠氮-炔环加成反应(CuAAC)合成。采用MTT法对五种人癌细胞系(HL-60、SMMC-7721、A-549、MCF-7、SW480)进行的细胞毒性评估显示,这些糖基化衍生物中的一些具有良好的抗癌活性。在合成的化合物中,化合物21a显示出最高的活性,IC50值在0.49至6.70 μM之间,比对照药物依托泊苷和顺铂更为强效。化合物21a的特点是具有全丁酰化的α-D(+)-半乳糖基残基,糖残基与三唑环之间没有额外的连接间隔,并且在鬼臼毒素骨架的E环上有一个4'-OH基团。
  • Antitumor agents. Part 227: Studies on novel 4′-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II
    作者:Zhiyan Xiao、Kenneth F Bastow、John R Vance、Kuo-Hsiung Lee
    DOI:10.1016/j.bmc.2004.03.067
    日期:2004.6
    epipodophyllotoxin derivatives (6-13), which were designed to overcome drug resistance and enhance topoisomerase II inhibition, were synthesized and evaluated. Two of these compounds (7 and 8) showed better preclinical activity profiles, including cell growth inhibition, cell killing, and in vitro topoisomerase II inhibition, as compared to the prototype molecule etoposide (1). They also retained the superior drug-resistance
    合成并评估了八种新颖的表鬼臼毒素衍生物(6-13),这些衍生物旨在克服耐药性并增强对拓扑异构酶II的抑制作用。与原型分子依托泊苷(1)相比,这些化合物中的两种(7和8)显示出更好的临床前活性,包括细胞生长抑制,细胞杀伤和体外拓扑异构酶II抑制。他们还保留了目前正在临床评估中的表鬼臼毒素衍生物GL-331(4)的优异抗药性。
查看更多

同类化合物

鬼臼脂毒酮 鬼臼毒素-4-O-葡萄糖苷 鬼臼毒素 鬼臼毒素 苦鬼臼毒素 脱氧鬼臼毒素 磷酸依托泊甙 盾叶鬼臼素 澳白木脂素2 澳白木脂素1 替尼泊苷 托尼依托泊苷 去氧鬼臼毒素 克立米星C 他氟泊苷 丙氨酸,N-(羧基甲基)-(9CI) alpha-盾叶鬼臼素 alpha-依托泊苷 [(5R,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-8-氧代-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-5-基]丁酸酯 TOP-53二盐酸盐 NK-611盐酸盐 5,8,8a,9-四氢-9-羟基-5-(3,4,5-三甲氧基苯基)-(5R,5aR,8aR,9S)-呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5aH)-酮 4’-去甲鬼臼毒素 4’-去甲基表鬼臼毒素-Β-D-葡萄糖甙 4-{[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]氨基甲酰}苯基乙酸酯 4,6-O-苄叉-Β-D-葡萄糖甙鬼臼毒素 4'-去甲基表鬼臼毒素 4'-O-脱甲基-4-((4'-(1'-苯甲基哌啶基))氨基)-4-脱氧鬼臼毒 4 ’-去甲去氧鬼臼毒素 3-羟基-4H-吡喃-4-酮 3-氨基-N-[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]苯酰胺 2’-O-没食子酰基金丝桃甙 2(3H)-硫代酰苯,3-乙基二氢-3-(1-甲基乙基)-(9CI) 2'-氯依托泊苷 1-羟基-17-氧杂五环[6.6.5.0~2,7~.0~9,14~.0~15,19~]十九碳-2,4,6,9,11,13-六烯-16,18-二酮(non-preferredname) (8aR,9S)-9-[[(2R)-7,8-二羟基-2-(2-噻吩基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5S,5aS,8aR,9R)-5-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基-苯基)-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-8-酮 (5S,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-5-(4-羟基苯基)硫烷基-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二噁唑-8-酮 (5R,5aR,8aS,9S)-9-[(4-氨基苯基)氨基]-5-(4-羟基-3,5-二甲氧苯基)-5,8,8a,9-四氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-6(5aH)-酮盐酸(1:1) (5R,5aR,8aR,9R)-9-羟基-10-甲氧基-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(4-甲氧基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(2-羟基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-8-羰基-9-(3,4,5-三甲氧苯基)-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基乙酸酯 (5R,5aR,8aR,9R)-5-(4-乙氧基-3,5-二甲氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-5-(3,5-二甲氧基-4-丙氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R)-5,8,8ab,9-四氢-5b-(3,4,5-三甲氧基苯基)呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5abH),9-二酮 (5-氯吡啶-3-基)丙酸甲酯 (3aS,4S,9R,9aR)-4-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基苯基)-6,7-二甲氧基-3a,4,9,9a-四氢-3H-萘并[3,2-c]呋喃-1-酮 (3aR,4S,9R,9aR)-4,6,7-三羟基-9-(4-羟基-3,5-二甲氧苯基)-3a,4,9,9a-四氢萘并[2,3-c]呋喃-1(3H)-酮 (1R,3aS,4R,6aR)-4-(1,3-苯并二氧戊环-4-基)-1-(1,3-苯并二氧戊环-5-基)-3,3a,4,6a-四氢-1H-呋喃并[3,4-c]呋喃-6-酮